Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $3.5K | $4.8K | $3.5K | $1.6K | $314 | $0 | $0 |
| Gross profit | $0 | −$3.5K | −$4.8K | −$3.5K | −$1.6K | −$314 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $0 | $1.6M | $324.6K | $14.4K | $0 | $55.2K | $83.8K | $92.2K |
| Operating income | −$62.2K | −$4.5M | −$4.1M | −$915.2K | −$5.4M | −$248.0K | $141.1K | −$4.2M |
| EBITDA | −$62.2K | −$4.5M | −$4.1M | −$912.9K | −$555.0K | −$247.0K | $254.7K | −$380.0K |
| Net income | −$62.2K | −$4.4M | −$4.1M | −$936.4K | −$5.3M | −$876.0K | −$687.0K | −$4.4M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.01 | -0.07 | -0.06 | -0.01 | -0.08 | -0.01 | -0.01 | -0.01 |
Annual figures · source: Financial Modeling Prep
ACTAVIA LIFE SCIENCES INC
No one on the platform currently holds RASP.
No tracked institution reports a position in RASP as of their last filing.
| Execution date | Ratio |
|---|---|
| 2016-09-20 | 3.25-for-1 |
No one on the platform has traded RASP yet.
| $90309 |
| — |
| NBIONascent Biotech, Inc. | $0.00 | +0.00% | $86109 | — |
| PDMIParadigm Medical Industries, Inc. | $0.00 | +0.00% | $324879 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.